156 related articles for article (PubMed ID: 38510295)
1. Cross-Disease Communication in Cardiovascular Disease and Cancer.
Von Itter R; Moore KJ
JACC CardioOncol; 2024 Feb; 6(1):67-70. PubMed ID: 38510295
[TBL] [Abstract][Full Text] [Related]
2. Heart Failure Post-Myocardial Infarction Promotes Mammary Tumor Growth Through the NGF-TRKA Pathway.
Tani T; Oikawa M; Misaka T; Ishida T; Takeishi Y
JACC CardioOncol; 2024 Feb; 6(1):55-66. PubMed ID: 38510296
[TBL] [Abstract][Full Text] [Related]
3. Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF.
Qin F; Vulapalli RS; Stevens SY; Liang CS
Am J Physiol Heart Circ Physiol; 2002 Jan; 282(1):H363-71. PubMed ID: 11748083
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor promotes cardiac repair following myocardial infarction.
Meloni M; Caporali A; Graiani G; Lagrasta C; Katare R; Van Linthout S; Spillmann F; Campesi I; Madeddu P; Quaini F; Emanueli C
Circ Res; 2010 Apr; 106(7):1275-84. PubMed ID: 20360245
[TBL] [Abstract][Full Text] [Related]
5. Direct interaction of TrkA/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cells.
Trouvilliez S; Cicero J; Lévêque R; Aubert L; Corbet C; Van Outryve A; Streule K; Angrand PO; Völkel P; Magnez R; Brysbaert G; Mysiorek C; Gosselet F; Bourette R; Adriaenssens E; Thuru X; Lagadec C; de Ruyck J; Orian-Rousseau V; Le Bourhis X; Toillon RA
J Exp Clin Cancer Res; 2022 Mar; 41(1):110. PubMed ID: 35346305
[TBL] [Abstract][Full Text] [Related]
6. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.
Davidson B; Reich R; Lazarovici P; Ann Flørenes V; Nielsen S; Nesland JM
Breast Cancer Res Treat; 2004 Jan; 83(2):119-28. PubMed ID: 14997042
[TBL] [Abstract][Full Text] [Related]
7. Expression and Signaling Pathways of Nerve Growth Factor (NGF) and Pro-NGF in Breast Cancer: A Systematic Review.
Bruno F; Arcuri D; Vozzo F; Malvaso A; Montesanto A; Maletta R
Curr Oncol; 2022 Oct; 29(11):8103-8120. PubMed ID: 36354700
[TBL] [Abstract][Full Text] [Related]
8. Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of Cardiology.
Nobre Menezes M; Tavares da Silva M; Magalhães A; Melica B; Toste JC; Calé R; Almeida M; Fiuza M; Infante de Oliveira E
Rev Port Cardiol; 2024 Jan; 43(1):35-48. PubMed ID: 37482119
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Electroacupuncture at Different Acupoints on Expression of NGF and TrkA in Cerebral Cortex in Rats with Myocardial Ischemia].
Hao F; Liu L; Wu ZJ; Hu L; Wang J; Yu Q; Cai RL; He L
Zhen Ci Yan Jiu; 2018 Jul; 43(7):400-5. PubMed ID: 30094974
[TBL] [Abstract][Full Text] [Related]
10. Apocynin prevents reduced myocardial nerve growth factor, contributing to amelioration of myocardial apoptosis and failure.
Jie X; Yang H; Wang K; Zhu ZF; Wang JP; Yang LG; Yang ZJ; Zhang XJ; Wang AL; Li L; Chi RF; Qin FZ; Li B; Fan B
Clin Exp Pharmacol Physiol; 2021 May; 48(5):704-716. PubMed ID: 33650189
[TBL] [Abstract][Full Text] [Related]
11. Cardio-Oncology - A new subspecialty with collaboration at its heart.
Ghosh AK; Walker JM
Indian Heart J; 2017; 69(4):556-562. PubMed ID: 28822531
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor cooperates with p185(HER2) in activating growth of human breast carcinoma cells.
Tagliabue E; Castiglioni F; Ghirelli C; Modugno M; Asnaghi L; Somenzi G; Melani C; Ménard S
J Biol Chem; 2000 Feb; 275(8):5388-94. PubMed ID: 10681513
[TBL] [Abstract][Full Text] [Related]
13. Reverse cardio-oncology: A budding concept.
Satpathy C; Kumar Mishra T; Singh S; Jha AK
Indian Heart J; 2023; 75(6):398-402. PubMed ID: 37774949
[TBL] [Abstract][Full Text] [Related]
14. Involvement of nerve growth factor in the ovulatory cascade: trkA receptor activation inhibits gap junctional communication between thecal cells.
Mayerhofer A; Dissen GA; Parrott JA; Hill DF; Mayerhofer D; Garfield RE; Costa ME; Skinner MK; Ojeda SR
Endocrinology; 1996 Dec; 137(12):5662-70. PubMed ID: 8940397
[TBL] [Abstract][Full Text] [Related]
15. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D
Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967
[TBL] [Abstract][Full Text] [Related]
16. Cardiac risk stratification of breast cancer patients in a cardio-oncology clinic.
Doukas PG; Patel RN; Venkatesh V; Khan SS; Baldridge A; Akhter N
Breast Cancer Res Treat; 2021 Nov; 190(1):133-142. PubMed ID: 34390418
[TBL] [Abstract][Full Text] [Related]
17. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
[TBL] [Abstract][Full Text] [Related]
18. NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.
Bradshaw RA; Pundavela J; Biarc J; Chalkley RJ; Burlingame AL; Hondermarck H
Adv Biol Regul; 2015 May; 58():16-27. PubMed ID: 25491371
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles of microRNA-208a in cardiology and reverse cardio-oncology.
Wang X; Chen X; Xu H; Zhou S; Zheng Y; Keller BB; Cai L
Med Res Rev; 2021 Jul; 41(4):2172-2194. PubMed ID: 33533026
[TBL] [Abstract][Full Text] [Related]
20. Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart.
Tocchetti CG; Ameri P; de Boer RA; D'Alessandra Y; Russo M; Sorriento D; Ciccarelli M; Kiss B; Bertrand L; Dawson D; Falcao-Pires I; Giacca M; Hamdani N; Linke WA; Mayr M; van der Velden J; Zacchigna S; Ghigo A; Hirsch E; Lyon AR; Görbe A; Ferdinandy P; Madonna R; Heymans S; Thum T
Cardiovasc Res; 2020 Sep; 116(11):1820-1834. PubMed ID: 32683451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
